A current view on the MRI diagnosis of multiple sclerosis: an update of 2016 revised MRI criteria

Close metadata

Recommended articles:

Assessment of the significance of dilated perivascular spaces and nocture arterial hypertension in the development of Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):33-40

The effectiveness of tele-rehabilitation for patients with multiple sclerosis during the COVID-19 pandemic in 2020—2021 was evaluated in this study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):75-81

Long-term efficacy and safety of divozilimab during 2-year treatment of multiple sclerosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):86-96

A case of COVID-associated encephalopathy in a patient with multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):159-163

Optical coherence tomography angiography in the diagnosis of multiple sclerosis. Russian Annals of Ophthalmology. 2024;(2):63-70

Focal cortical dysplasia: visual assessment of MRI and MR morphometry data. Burdenko's Journal of Neurosurgery. 2024;(3):45-51

A role of cerebrovascular diseases in the progression of multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):53-57

Optical coherence tomography in the diagnosis of multiple sclerosis. Russian Annals of Ophthalmology. 2024;(3):59-68

Questionnaires for arm function assessment in patients with multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):36-42

Features of primary forms of headache in multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):70-73

Magnetic resonance imaging (MRI) is the primary method for confirming the clinical diagnosis of multiple sclerosis (MS). The article presents the current data on using MRI of the brain and spinal cord for diagnosis in suspected MS. Special attention is paid to the MRI criteria of McDonald and MAGNIMS for relapsing-remitting MS (RRMS) and primary-progressive MS (PPMS) in the latest revisions of 2010 and 2016. The information provided can help radiologists and neurologists to optimize the use of MRI in clinical practice for diagnosis of MS.

Keywords:

magnetic resonance imaging

multiple sclerosis

MRI criteria

relapsing-remitting MS

primary progressive MS

Authors:

Briukhov V.V.

Krotenkova I.A.

FGBU "Nauchnyĭ tsentr nevrologii" RAN, Moskva

Morozova S.N.

Research Center of Neurology, Russian Academy of Sciences, Moscow

Krotenkova M.V.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

List of references:

McDonald WI et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology. 2001;50:121-127. doi:10.1002/ana.1032
Polman CH et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the «McDonald Criteria». Annals of Neurology. 2005;58:840-846. doi:10.1002/ana.20703
Polman CH et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of Neurology. 2011;69:292-302. doi:10.1002/ana.22366
Poser CM et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals of Neurology. 1983;13:227-231. doi:10.1002/ana.410130302
Charil A et al. MRI and the diagnosis of multiple sclerosis: expanding the concept of «no better explanation». The Lancet Neurology. 2006;5:841-852. doi:10.1016/s1474-4422(06)70572-5
Miller DH et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Multiple Sclerosis Journal. 2008;14:1157-1174. doi:10.1177/1352458508096878
Montalban X et al. MRI criteria for MS in patients with clinically isolated syndromes. Neurology. 2010;74:427-434. doi:10.1212/wnl.0b013e3181cec45c
Filippi M, Rocca M, Ciccarelli O et al. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. The Lancet Neurology. 2016;15(3):292-303. doi:10.1016/s1474-4422(15)00393-2
Montalban X et al. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal. Multiple Sclerosis Journal. 2009;15:1459-1465. doi:10.1177/1352458509348422
Dobson R, Ramagopalan S, Davis A, Giovannoni G. Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. Journal of Neurology, Neurosurgery & Psychiatry. 2013;84:909-914 doi: 10.1136/jnnp-2012-304695
Kelly SB et al. A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis. Multiple Sclerosis Journal. 2013;19:1095-1100. doi:10.1177/1352458512464829
Rovira A at al. MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis — clinical implementation in the diagnostic process. Nature Reviews Neurology. 2015;11:471-482. doi:10.1038/nrneurol.2015.106
Sadaka Y et al. 2010 McDonald criteria for diagnosing pediatric multiple sclerosis. Annals of Neurology. 2012;72:211-223. doi:10.1002/ana.23575
Kornek B et al. Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome. Multiple Sclerosis Journal. 2012;18:1768-1774. doi:10.1177/1352458512444661
Huh SY et al. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders. Multiple Sclerosis Journal. 2014;20:695-704. doi:10.1177/1352458513506953
Absinta M, Rocca M, Colombo B et al. Patients with migraine do not have MRI-visible cortical lesions. Neurology. 2012;259:2695-2698. doi:10.1007/s00415-012-6571-x
Ruet A, Arrambide G, Brochet B et al. Early predictors of multiple sclerosis after a typical clinically isolated syndrome. Multiple Sclerosis Journal. 2014;20:1721-1726. doi:10.1177/1352458514533397
Ruet A, Deloire M, Ouallet J, Molinier S, Brochet B. Predictive factors for multiple sclerosis in patients with clinically isolated spinal cord syndrome. Multiple Sclerosis Journal. 2011;17:312-318. doi:10.1177/1352458510386999
Moraal B, Pohl C, Uitdehaag B, et al. Magnetic resonance imaging predictors of conversion to multiple sclerosis in the BENEFIT study. Archives of Neurology. 2009;66:1345-1352. doi:10.1001/archneurol.2009.243
Kim S, Richman D, Johnson W, Hald J, Agius M. Limited utility of current MRI criteria for distinguishing multiple sclerosis from common mimickers: primary and secondary CNS vasculitis, lupus and Sjogren’s syndrome. Multiple Sclerosis Journal. 2014;20:57-63. doi:10.1177/1352458513491329
Kidd D, Barkhof F, McConnell R, Algra P, Allen I, Revesz T. Cortical lesions in multiple sclerosis. Brain. 1999;122:17-26. doi:10.1093/brain/122.1.17
Geurts J, Pouwels P, Uitdehaag B, Polman C, Barkhof F, Castelijns J. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology. 2005;236:254-260. doi:10.1148/radiol.2361040450
Seewann A, Kooi E, Roosendaal S. et al. Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology. 2012;78:302-308. doi:10.1212/wnl.0b013e31824528a0
Kelly S, Kinsella K, Duggan M, Tubridy N, McGuigan C, Hutchinson M. A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis. Multiple Sclerosis Journal. 2012;19(8):1095-1100. doi:10.1177/1352458512464829
Bryukhov VV, Popova EV, Krotenkova IA, Boyko AN. Radiologically isolated syndrome — MRI criteria and management tactics. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2016;116:10(2):52-57. (In Russ.).
Huh SY et al. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders. Multiple Sclerosis Journal. 2014;20:695-704. doi:10.1177/1352458513506953
Wattjes MP et al. Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis. Neuroradiology. 2008;50:123-129. doi:10.1007/s00234-007-0325-y
Filippi M, Agosta F. Imaging biomarkers in multiple sclerosis. Journal of Magnetic Resonance Imaging. 2010;31:770-788. doi:10.1002/jmri.22102
Rovaris M et al. A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS. Journal of Neurology. 2008;255:1209-1214. doi:10.1007/s00415-008-0877-8
Barcella V et al. Evidence for retrochiasmatic tissue loss in Leber’s hereditary optic neuropathy. Human Brain Mapping. 2010;31:1900-1906. doi:10.1002/hbm.20985
Yu C et al. Pathogenesis of normal-appearing white matter damage in neuromyelitis optica: diffusion-tensor MR imaging. Radiology. 2008;246:222-228. doi:10.1148/radiol.2461062075
Kang H et al. Application and a proposed modification of the McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes. Multiple Sclerosis Journal. 2014;20:458-463. doi:10.1177/1352458513475492
Mitjana R et al. Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromes. Multiple Sclerosis Journal. 2014;20:1471-1477. doi:10.1177/1352458514526083
Bryukhov VV, Kulikova SN, Krotenkova MV, Peresedova AV, Zavalishin IA. State-of-the-art neuroimaging techniques in pathogenesis of multiple sclerosis. Annaly klinicheskoj i jeksperimental'noj nevrologii. 2013;3:47-53. (In Russ.).
Tallantyre EC et al. Ultra‑high‑field imaging distinguishes MS lesions from asymptomatic white matter lesions. Neurology. 2011;76:534-539. doi:10.1212/wnl.0b013e31820b7630
Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magnetic Resonance in Medicine. 2004;52:612-618. doi:10.1002/mrm.20198
Kilsdonk ID et al. Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla. European Radiology. 2014;24:841-849. doi:10.1007/s00330-013-3080-y
Absinta M et al. Seven-tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process. Annals of Neurology. 2013;74:669-678. doi:10.1002/ana.23959
Kau T et al. The «central vein sign»: is there a place for susceptibility weighted imaging in possible multiple sclerosis? European Radiology. 2013;23:1956-1962. doi:10.1007/s00330-013-2791-4
Sati P et al. Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis. Multiple Sclerosis Journal. 2014;20:1464-1470. doi:10.1177/1352458514525868
Hagemeier J et al. Phase white matter signal abnormalities in patients with clinically isolated syndrome and other neurologic disorders. American Journal of Neuroradiology. 2014;35:1916-1923. doi:10.3174/ajnr.a3969
Simon B et al. Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. European Radiology. 2010;20:1675-1683. doi:10.1007/s00330-009-1705-y
Filippi M et al. Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology. 2010;75:1988-1994. doi:10.1212/wnl.0b013e3181ff96f6
Pestalozza IF et al. Monthly brain magnetic resonance imaging scans in patients with clinically isolated syndrome. Multiple Sclerosis Journal. 2005;11:390-394. doi:10.1191/1352458505ms1175oa
Lebrun C et al. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients. Archives of Neurology. 2009;66:841-846. doi:10.1001/archneurol.2009.119
Bryukhov VV, Krotenkova IA, Morozova SN, Krotenkova MV. Standardization of MRI studies in multiple sclerosis. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2016;116:10(2):27-34. (In Russ.).

Close metadata